Emgality Loading Dose Requirements (galcanezumab)
Emgality requires an initial 240 mg loading dose only for migraine prevention in adults. [1] For episodic cluster headache, the recommended initial dosing is a 300 mg dose at the start of the cluster period, without a separate “loading dose” step beyond that initial regimen. [1]
Migraine Prevention Dosing
For prevention of migraine in adults, the recommended dosage is:
- 240 mg once as a loading dose (administered as two consecutive subcutaneous injections of 120 mg each). [1]
- 120 mg subcutaneously once monthly as maintenance. [1]
Episodic Cluster Headache Dosing
For prevention of episodic cluster headache in adults, the recommended dosage is:
- 300 mg subcutaneously once at the onset of the cluster period (administration is by multiple injections per the labeled regimen). [1]
- 300 mg subcutaneously once monthly until the end of the cluster period. [1]
Key Documentation Supporting the Loading Dose
The U.S. FDA prescribing information for Emgality specifies a 240 mg loading dose for migraine prevention and monthly 120 mg maintenance dosing after the loading dose. [1]
Initiation Clarifications
- The “loading dose” terminology in the labeled regimen applies to the 240 mg first-month regimen for migraine prevention. [1]
- The episodic cluster headache regimen uses an initial 300 mg dose at cluster onset rather than a separate loading-dose concept. [1]
Common Pitfalls to Avoid
- Administering only 120 mg at initiation for migraine prevention instead of the labeled 240 mg first-month loading dose. [1]
- Confusing the episodic cluster headache initial 300 mg at cluster onset with migraine prevention’s 240 mg loading dose. [1]
Patient-Specific Selection Considerations
Selection of the correct initial regimen depends on the labeled indication: migraine prevention uses the 240 mg loading dose, whereas episodic cluster headache uses the 300 mg dose at cluster onset. [1]